Apoptosis Analysis of Jurkat Cells using the Cellometer® Vision

Post on 03-Feb-2022

4 views 0 download

Transcript of Apoptosis Analysis of Jurkat Cells using the Cellometer® Vision

Apoptosis Analysis of Jurkat Cells using the Cellometer® Vision

Leo L. Chan1, Ph.D. Tim Smith 2, M.S., Alnoor Pirani 2, Ph.D., Emily Lyette� 2, M.S., Ning Lai2, Ph.D., Jean Qiu 1, Ph.D., and Bo Lin 2, Ph.D.

1Department of Technology R&D2Department of Applications

1. ABSTRACT

2. INTRODUCTION

6. APOPTOSIS ANALYSIS – 2-amino-N-quinoline-8-yl-benzenesulfonamide (QBS)

7. APOPTOSIS ANALYSIS – α-Tocopheryl succinate (α-TOS)

5. JC-1 MITOCHONDRIAL POTENTIAL DETECTION

4. JURKAT CELLS PREPARATION & STAINING PROTOCOL

3. CELLOMETER® VISION & CELL COUNTING METHOD

Nexcelom Bioscience LLC, 360 Merrimack St. Building 9, Lawrence, Massachusetts

Pipette 20µL of sample into disposable counting chamber

Insert chamber in Cellometer

Bright-field (BR) and fluorescent (FL) images acquired and analyzed

Output data generated instantly

Results• The JC-1 stain produces green & red fluorescence wavelengths• The CCCP disruptor reduced the red fluorescence significantly• Data analysis

• The bright field cells are counted individually• The counted cells are examined in green & red channels• The fluorescence intensity are calculated and plotted

• The results indicate that using Cellometer® Vision with JC-1stains, early stages of apoptosis can be detected by examiningthe mitochondrial membrane potential

Results• QBS induced apoptosis in Jurkat cells• Cellometer® can measure levels of apoptosis at different

concentrations of QBS• Annexin V-FITC and Propidium Iodide are both detected

Results• α-TOS induced apoptosis in Jurkat cells• Cellometer® can measure levels of apoptosis at different

concentrations of α-TOS• Annexin V-FITC and Propidium Iodide are both detected

9. CONCLUSION & ACKNOWLEGEMENTWe have demonstrated a rapid and cost-effective method for apoptosis analysis using the Cellometer® Vision. TheCellometer® Vision has the capability of capturing bright-field and two fluorescent images that can analyzeapoptotic and nonviable cells labeled with Annexin V-FITC and Propidium Iodide, respectively. This method allowsusers to quickly obtain results for mitochondrial potential and apoptosis measurement, while eliminating inherentissues from manual hemacytometer and flow cytometer. The Cellometer® Vision enables simpler researchdevelopment in both academia and industry.The authors would like to thank the Biotechnology Center at the Merrimack College, North Andover, MA forproviding support in this work.

• JC-1 Staining Procedure– Obtain JC-1 Kit reagent from Invitrogen– Centrifuge Jurkat cells at 1500 RPM for 5 min and remove supernatant– Resuspend cells in 1 ml of warm PBS– Prepare two tubes of cells at 1 ml and approximately 2 x 106 cells/ml– Label one tube as the disrupted and the other as normal– For the disrupted tube, add 1 μl of 50 mM CCCP (as supplied)– For both tubes, add 10 μl of 200 μM JC-1 and incubate at 37°C, 5% CO2 for 15-30 min

• Annexin-V-FITC & Propidium Iodide (PI) Staining Procedure– Obtain the Annexin-V Binding Buffer, Annexin-V-FITC, and PI from BioLegend– Centrifuge Jurkat cells at 1500 RPM for 5 min and remove supernatant– Resuspend in 1 ml of warm PBS at approximately 2 x 106 cells/ml– Mix 100 μl of cells with 5 μl of Annexin-V-FITC and 10 μl of PI– Incubate at room temperature for 15-30 min in the dark

• Jurkat Cells Preparation– Jurkat cells are cultured in incubator (37°C, 5% CO2) for mitochondrial potential study– Jurkat cells are induced with α-TOS and QBS from 10-100 μM and 0.001 to 100 μM,

respectively, for apoptosis study

1.0E+00

1.0E+01

1.0E+02

1.0E+03

1.0E+04

1.0E+05

1.0E+00 1.0E+01 1.0E+02 1.0E+03 1.0E+04 1.0E+05

FL2-

Red

Fluo

resc

ence

FL1-Green Fluorescence

NormalDisrupted

Normal

Normal

Disrupted

DisruptedBright-Field

Red Fluorescence

Green Fluorescence

Disrupted Red Fluorescence

We demonstrate a rapid and cost-effective method for apoptosis analysis at various stagesof Jurkat cells using the Cellometer® Vision. This method has the ability to eliminate manyknown issues caused by manual hemacytometer and flow cytometer. By using Cellometer®Vision, the assay time for obtaining apoptosis result is greatly reduced, which is significantfor research development in academia and industry.

The current methods for apoptosis analysis utilizes standard flow cytometry, but severalinherent issues are attached. Standard flow cytometry is expensive, large in size, andrequire considerable amount of maintenance. In addition, most of the flow cytometers donot have imaging capabilities, which often generate some uncertainties in the fluorescenceresults obtained. Recently, a novel imaging cytometry platform, equivalent of combiningfluorescent microscope and flow cytometry, has been developed by Nexcelom Bioscience(Lawrence, MA). This new device allows rapid analysis using inexpensive disposablecounting chambers that require only 20 μl of samples. This system allows automated cellimage acquisition and processing with a novel counting algorithm for accurate andconsistent measurement of cell population and viability on a variety of cell types(immunological, cancer, stem, insect, adipocytes, hepatocytes, platelets, algae, andheterogeneous cells). In this work, the mitochondrial potential with JC-1 and apoptosismeasurement using Annexin V-FITC and Propidium Iodide is explored using Cellometer®.

1

10

100

1 10 100 1000

FL2-

Ann

exin

V-F

ITC

FL1-Propidium Iodide

100 μM

1

10

100

1 10 100 1000

FL2-

Ann

exin

V-F

ITC

FL1-Propidium Iodide

Control

[QBS] (μM) 0 0.001 0.01 0.1 1 10 100

Q1 92.97% 89.30% 89.05% 91.12% 83.47% 77.97% 49.09%

Q2 0.69% 2.34% 1.37% 1.72% 4.58% 1.57% 3.89%

Q3 4.35% 5.82% 7.64% 5.02% 3.74% 4.49% 7.29%

Q4 2.00% 2.53% 1.95% 2.14% 8.20% 15.97% 39.73%

Cells/ml 9.61E+06 8.69E+06 7.63E+06 8.97E+06 4.56E+06 5.27E+06 4.52E+06

1

10

100

1 10 100 1000

FL2-

Ann

exin

V-F

ITC

FL1-Propidium Iodide

Control

1

10

100

1000

1 10 100 1000

FL2-

Ann

exin

V-F

ITC

FL1-Propidium Iodide

100 μM

[α-TOS] μM 0 10 20 30 40 60 80 100

Q1 90.30% 92.86% 91.59% 90.25% 90.97% 26.56% 20.00% 18.18%

Q2 1.39% 1.06% 0.78% 1.23% 2.18% 9.38% 26.67% 72.73%

Q3 6.16% 4.50% 5.30% 6.31% 2.49% 0.00% 0.00% 0.00%

Q4 2.16% 1.59% 2.33% 2.21% 4.36% 64.06% 53.33% 9.09%

Cells/ml 7.14E+06 6.23E+06 4.25E+06 6.71E+06 3.53E+06 3.52E+05 8.25E+04 6.05E+04